Circio Holding ASA (OSL:CRNA)
kr 0.724 0.016 (2.26%) Market Cap: 37.92 Mil Enterprise Value: 70.08 Mil PE Ratio: 0.98 PB Ratio: 0 GF Score: 1/100

Targovax ASA Corporate Analyst Meeting Transcript

Jun 25, 2020 / 03:30PM GMT
Release Date Price: kr181.39 (+2.32%)
Nicholas Colangelo;SOLEBURY TROUT LLC;Analyst

Thank you for attending the European Biotech Investor Day hosted by Solebury Trout, Goodwin, Deutsche Bank and Nasdaq. My name is Nick Colangelo. I'm an analyst here at Solebury Trout.

Before I introduce the next speaker, I would like to remind you to please feel free to submit your questions throughout the presentation via the web platform. If the company does not have time to answer them during the presentation, they will follow-up individually.

And with that said, it is my pleasure to introduce the next speaker, Dr. Magnus Jäderberg, Chief Medical Officer of Targovax. Magnus, please go ahead.

Magnus JÃ;derberg
Targovax ASA - Chief Medical Officer

¤ -

Thank you very much, Nick, and welcome to my talk. So Targovax is a Norwegian biotech company focusing on immuno-oncology products. And I have the pleasure today to talk to you about what we're up to. And my talk will fall into introductory part, mesothelioma and melanoma, which are our sponsored

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot